Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of GBP 204.74 billion. The enterprise value is 222.90 billion.

Market Cap	204.74B
Enterprise Value	222.90B

Important Dates

The next confirmed earnings date is Tuesday, April 28, 2026.

Earnings Date	Apr 28, 2026
Ex-Dividend Date	Mar 11, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-3.80%
Shares Change (QoQ)	-0.67%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	43.83%
Float	1.82B

Valuation Ratios

The trailing PE ratio is 19.98 and the forward PE ratio is 16.59.

PE Ratio	19.98
Forward PE	16.59
PS Ratio	4.78
PB Ratio	6.95
P/TBV Ratio	n/a
P/FCF Ratio	15.42
P/OCF Ratio	14.10
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.66, with an EV/FCF ratio of 16.79.

EV / Earnings	21.75
EV / Sales	5.22
EV / EBITDA	12.66
EV / EBIT	15.91
EV / FCF	16.79

Financial Position

The company has a current ratio of 0.85, with a Debt / Equity ratio of 1.21.

Current Ratio	0.85
Quick Ratio	0.53
Debt / Equity	1.21
Debt / EBITDA	2.01
Debt / FCF	2.68
Interest Coverage	15.26

Financial Efficiency

Return on equity (ROE) is 34.93% and return on invested capital (ROIC) is 21.29%.

Return on Equity (ROE)	34.93%
Return on Assets (ROA)	10.63%
Return on Invested Capital (ROIC)	21.29%
Return on Capital Employed (ROCE)	21.31%
Weighted Average Cost of Capital (WACC)	6.39%
Revenue Per Employee	569,264
Profits Per Employee	136,173
Employee Count	75,267
Asset Turnover	0.52
Inventory Turnover	2.29

Taxes

In the past 12 months, Novartis AG has paid 1.72 billion in taxes.

Income Tax	1.72B
Effective Tax Rate	14.38%

Stock Price Statistics

The stock price has increased by +29.17% in the last 52 weeks. The beta is 0.52, so Novartis AG's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	+29.17%
50-Day Moving Average	155.84
200-Day Moving Average	136.84
Relative Strength Index (RSI)	34.94
Average Volume (20 Days)	236,268

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of GBP 42.85 billion and earned 10.25 billion in profits. Earnings per share was 5.29.

Revenue	42.85B
Gross Profit	32.36B
Operating Income	14.07B
Pretax Income	11.95B
Net Income	10.25B
EBITDA	17.48B
EBIT	14.07B
Earnings Per Share (EPS)	5.29

Balance Sheet

The company has 5.28 billion in cash and 35.59 billion in debt, giving a net cash position of -30.31 billion.

Cash & Cash Equivalents	5.28B
Total Debt	35.59B
Net Cash	-30.31B
Net Cash Per Share	n/a
Equity (Book Value)	29.48B
Book Value Per Share	15.28
Working Capital	-3.61B

Cash Flow

In the last 12 months, operating cash flow was 14.52 billion and capital expenditures -1.24 billion, giving a free cash flow of 13.28 billion.

Operating Cash Flow	14.52B
Capital Expenditures	-1.24B
Depreciation & Amortization	3.34B
Net Borrowing	10.77B
Free Cash Flow	13.28B
FCF Per Share	n/a

Margins

Gross margin is 75.52%, with operating and profit margins of 32.83% and 23.92%.

Gross Margin	75.52%
Operating Margin	32.83%
Pretax Margin	27.90%
Profit Margin	23.92%
EBITDA Margin	40.79%
EBIT Margin	32.83%
FCF Margin	30.99%

Dividends & Yields

This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 2.02%.

Dividend Per Share	3.00
Dividend Yield	2.02%
Dividend Growth (YoY)	14.97%
Years of Dividend Growth	4
Payout Ratio	64.15%
Buyback Yield	3.80%
Shareholder Yield	5.81%
Earnings Yield	5.01%
FCF Yield	6.49%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5